Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A.
Haematologica
View this publicationHaematologica
View this publicationPharmacoepidemiology and drug safety
View this publicationNature
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationEuropean journal of nuclear medicine and molecular imaging
View this publicationScientific reports
View this publicationHepatology communications
View this publicationScientific reports
View this publicationBMJ (Clinical research ed.)
View this publicationInternational journal of rheumatic diseases
View this publication